The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis ; volume:21 ; number:1 ; day:8 ; month:1 ; year:2020 ; pages:1-9 ; date:12.2020
Respiratory research ; 21, Heft 1 (8.1.2020), 1-9, 12.2020
- Urheber
-
Tran, Tanja
Šterclová, Martina
Mogulkoc, Nesrin
Lewandowska, Katarzyna
Müller, Veronika
Hájková, Marta
Kramer, Mordechai R.
Jovanović, Dragana
Tekavec-Trkanjec, Jasna
Studnicka, Michael
Stoeva, Natalia
Hejduk, Karel
Dušek, Ladislav
Suissa, Samy
Vašáková, Martina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1271-z
- URN
-
urn:nbn:de:101:1-2020041408080967153387
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tran, Tanja
- Šterclová, Martina
- Mogulkoc, Nesrin
- Lewandowska, Katarzyna
- Müller, Veronika
- Hájková, Marta
- Kramer, Mordechai R.
- Jovanović, Dragana
- Tekavec-Trkanjec, Jasna
- Studnicka, Michael
- Stoeva, Natalia
- Hejduk, Karel
- Dušek, Ladislav
- Suissa, Samy
- Vašáková, Martina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort